-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

636.P1.26 636. Myelodysplastic Syndromes: Basic and Translational: Poster I Clinically Relevant Abstract

Symposia: Myelodysplastic Syndromes: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Fundamental Science, MDS, Translational Research, Chronic Myeloid Malignancies, Diseases, Myeloid Malignancies
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Stefania Leone1,2*, Francesco Grimaldi, MD3*, Mara Memoli4*, Flavia Carriero5*, Giulia Scalia6*, Annamaria Vincenzi7*, Giuseppe Cerciello8*, Fabrizio Pane9, Alessandra Picardi, MD10*, Giuseppe Terrazzano5*, Giuseppina Ruggiero11* and Valentina Rubino11*

1University federico II of Naples, Naples, Italy
2AORN Cardarelli, Naples, Italy
3Department of Clinical Medicine and Surgery, Hematology Unit, University of Naples Federico II, Napoli, Italy
4Department of Medicine and Surgery, Hematology and Hematopoietic Stem Cell Transplant Center, University of Naples Federico II, Naples, Naples, Italy
5Department of Sciences, University of Basilicata, Potenza, Italy
6Centre for Advanced Biotechnology (CEINGE), Naples, Italy
7Aou-Federico II, Naples, Naples, ITA
8Hematology, "San Pio" Hospital of Benevento, Naples, ITA
9Division of Hematology and SCT Unit, Federico II University, Naples, Naples, Italy
10Stem Cell Transplant Program AORN Cardarelli, Naples and Biomedicine and Prevencion Department of Tor Vergata University, Rome, Naples / Rome, Italy
11Department of Translational Medicine, University of Naples Federico II, Naples, Italy

Xuan Zhang, PhD1*, Guangyuan Li2*, Anna Oliverio3*, Jennifer VanOudenhove, PhD4, Amy E. DeZern, MD, MHS5,6, Gabriel Ghiaur, MD, PhD7, Stephanie Halene, MD8, H. Leighton Grimes, PhD9,10 and Nathan Salomonis, PhD11*

1Division of Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
2Perlmutter Cancer Center, New York University, New York City, NY
3Division of Biomedical Informatics, Cincinnati Children's Hosptial, Cincinnati, OH
4Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
5Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
6The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
7Division of Hematologic Malignancies, Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, John's Hopkins Hospital, Baltimore, MD
8Yale Univ. School of Medicine, New Haven, CT
9Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
10Division of Immunobiology, Cincinnati Children's Hospital, Cincinnati, OH
11Division of Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH

Valerie Awad, MS1* and Teresa V. Bowman, PhD2

1Developmental and Molecular Biology, Albert Einstein College of Medicine, New York
2Department of Oncology, Department of Molecular and Developmental Biology, Albert Einstein College of Medicine, New York, NY

Rahul Roy, MSc1*, Manoj Pillai, MD1 and Prajwal Boddu, MD2

1Yale University, New Haven, CT
2Yale University, East Lyme, CT

Rahul Roy, MSc1*, Abhishek Gupta1*, Manoj Pillai, MD1 and Prajwal Boddu, MD2

1Yale University, New Haven, CT
2Yale University, East Lyme, CT

Pawan Bhat, BSc1, Joseph C. Van Amburg, MS2*, Thomas J. Gracie, MD3*, Justin A Cartailler, BA4*, Chad R Potts, BS4*, Alexander G. Bick, MD, PhD5*, Robert Welner, PhD6 and Brent Ferrell Jr., MD4,7

1School of Medicine, Program in Cancer Biology, Vanderbilt University, Nashville, TN
2School of Medicine, Human Genetics Program, Vanderbilt University, Nashville, TN
3Internal Medicine Residency, Vanderbilt University Medical Center, Nashville, TN
4Department of Medicine, Vanderbilt University Medical Center, Nashville, TN
5Department of Medicine, Division of Genetic Medicine, Vanderbilt University Medical Center, Nashville, TN
6Division of Hematology and Oncology, Department of Medicine, UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
7Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN

Amro Baassiri, MD, PhD1*, Jamie Maziarz2*, Holly Nicole Blackburn, MD3*, Hannah Maul-Newby, PhD2*, Jennifer VanOudenhove, PhD1,4, Xuan Zhang, PhD5*, Martin Matthews, MS1*, Sambuddha Paul, MS2*, Wei Liu2*, Esen Sefik, PhD6*, Nathan Salomonis, PhD7*, H. Leighton Grimes, PhD8, Richard Flavell, PhD, FRS3* and Stephanie Halene, MD9

1Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT
2yale university, new haven
3Yale University, New Haven, CT
4Yale Cancer Center, Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT
5Division of Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
6Yale University School of Medicine, New Haven, CT
7Division of Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH
8Division of Immunobiology, Cincinnati Children's Hospital, Cincinnati, OH
9Yale Univ. School of Medicine, New Haven, CT

Jeremy Connors1*, Linda Zhang2*, Hidetaka Uryu, MD, PhD3*, Koji Sasaki, MD4, Jennifer Padilla2*, Zongrui Li5*, Ken Furudate, DMD, PhD4*, Tomoyuki Tanaka1*, Courtney D. DiNardo, MD, MSc6, Nicholas J. Short, MD4, Naval Daver, MD7, Gautham Borthakur8*, Farhad Ravandi, MBBS9, Tapan M. Kadia, MD4, Hagop M. Kantarjian, MD4, Elias Jabbour, MD10, Simona Colla, PhD11, Branko Cuglievan, MD12, Andrew Futreal, PhD13*, Adam S. Sperling, MD, PhD14, Guillermo Garcia-Manero, MD4, Margaret Goodell, PhD15 and Koichi Takahashi, MD, PhD16

1The University of Texas MD Anderson Cancer Center, Houston
2Baylor College of Medicine, Houston
3Leukemia, The UNIVERSITY of TEXAS, M.D. Anderson, Houston, TX
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Leukemia, MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
7MD Anderson Cancer Center, Houston, TX
8The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
10Department of Leukemia, University of Texas M.D. Anderson Cancer Ctr., Houston, TX
11Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
12Division of Pediatrics, MD Anderson Cancer Center, Houston, TX
13Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
14Dana-Farber Cancer Institute, Boston, MA
15Department of Molecular Cell Biology, Baylor College of Medicine, Houston, TX
16Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Maha M Kamel, MBioChem, BScPharm1,2*, Nirmal Robinson, M.Pharm, PhD3*, Monika Kutyna, PhD4,5*, Kelly Lim, MSc, BSc1,2*, Chloe Thompson-Peach, PhD1,2*, Steven W Lane, MBBS, PhD, FRCPA, FRACP6, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA5, Agnes S. M. Yong, MD, PhD2,7, David M Ross, MD, PhD, FRACP, FRCPA2,8*, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA5,9 and Daniel Thomas, MD, PhD, FRACP, FRCPA5,8,10

1Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
2South Australian Health and Medical Research Institute, Adelaide, Australia
3Centre for Cancer Biology, University of South Australia, Adelaide, Australia
4Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia
5South Australian Health and Medical Research Institute, Adelaide, SA, Australia
6Cancer Program, QIMR Berghofer Medical Research Institute, Royal Brisbane and Women’s Hospital, Brisbane, QLD, Australia
7Haematology Department, Royal Perth Hospital, Perth, Australia
8Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, Australia
9Department of Haematology, Central Adelaide Local Health Network, Adelaide, SA, Australia
10Central Adelaide Local Health Network, Adelaide, SA, Australia

*signifies non-member of ASH